Global Neuromodulation Devices and Implantable Infusion Pumps Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Neuromodulation Devices and Implantable Infusion Pumps market size was valued at US$ million in 2023. With growing demand in downstream market, the Neuromodulation Devices and Implantable Infusion Pumps is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Neuromodulation Devices and Implantable Infusion Pumps market. Neuromodulation Devices and Implantable Infusion Pumps are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Neuromodulation Devices and Implantable Infusion Pumps. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Neuromodulation Devices and Implantable Infusion Pumps market.
An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.
In United States, Neuromodulation Devices and Implantable Infusion Pumps key players include Medtronic, Boston Scientific Corporation, St. Jude Medical, etc. Global top three manufacturers hold a share over 75%.
Midwest is the largest market, with a share about 50%, followed by South, and West, both have a share over 45 percent.
In terms of product, Spinal Cord Stimulation is the largest segment, with a share over 50%. And in terms of application, the largest application is Pain, followed by Parkinson's disease, Epilepsy, etc.
Key Features:
The report on Neuromodulation Devices and Implantable Infusion Pumps market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Neuromodulation Devices and Implantable Infusion Pumps market. It may include historical data, market segmentation by Type (e.g., Spinal Cord Stimulation, Deep Brain Stimulation), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Neuromodulation Devices and Implantable Infusion Pumps market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Neuromodulation Devices and Implantable Infusion Pumps market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Neuromodulation Devices and Implantable Infusion Pumps industry. This include advancements in Neuromodulation Devices and Implantable Infusion Pumps technology, Neuromodulation Devices and Implantable Infusion Pumps new entrants, Neuromodulation Devices and Implantable Infusion Pumps new investment, and other innovations that are shaping the future of Neuromodulation Devices and Implantable Infusion Pumps.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Neuromodulation Devices and Implantable Infusion Pumps market. It includes factors influencing customer ' purchasing decisions, preferences for Neuromodulation Devices and Implantable Infusion Pumps product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Neuromodulation Devices and Implantable Infusion Pumps market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Neuromodulation Devices and Implantable Infusion Pumps market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Neuromodulation Devices and Implantable Infusion Pumps market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Neuromodulation Devices and Implantable Infusion Pumps industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Neuromodulation Devices and Implantable Infusion Pumps market.
Market Segmentation:
Neuromodulation Devices and Implantable Infusion Pumps market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Neuromodulation Devices and Implantable Infusion Pumps market?
What factors are driving Neuromodulation Devices and Implantable Infusion Pumps market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neuromodulation Devices and Implantable Infusion Pumps market opportunities vary by end market size?
How does Neuromodulation Devices and Implantable Infusion Pumps break out type, application?
According to our LPI (LP Information) latest study, the global Neuromodulation Devices and Implantable Infusion Pumps market size was valued at US$ million in 2023. With growing demand in downstream market, the Neuromodulation Devices and Implantable Infusion Pumps is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Neuromodulation Devices and Implantable Infusion Pumps market. Neuromodulation Devices and Implantable Infusion Pumps are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Neuromodulation Devices and Implantable Infusion Pumps. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Neuromodulation Devices and Implantable Infusion Pumps market.
An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.
In United States, Neuromodulation Devices and Implantable Infusion Pumps key players include Medtronic, Boston Scientific Corporation, St. Jude Medical, etc. Global top three manufacturers hold a share over 75%.
Midwest is the largest market, with a share about 50%, followed by South, and West, both have a share over 45 percent.
In terms of product, Spinal Cord Stimulation is the largest segment, with a share over 50%. And in terms of application, the largest application is Pain, followed by Parkinson's disease, Epilepsy, etc.
Key Features:
The report on Neuromodulation Devices and Implantable Infusion Pumps market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Neuromodulation Devices and Implantable Infusion Pumps market. It may include historical data, market segmentation by Type (e.g., Spinal Cord Stimulation, Deep Brain Stimulation), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Neuromodulation Devices and Implantable Infusion Pumps market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Neuromodulation Devices and Implantable Infusion Pumps market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Neuromodulation Devices and Implantable Infusion Pumps industry. This include advancements in Neuromodulation Devices and Implantable Infusion Pumps technology, Neuromodulation Devices and Implantable Infusion Pumps new entrants, Neuromodulation Devices and Implantable Infusion Pumps new investment, and other innovations that are shaping the future of Neuromodulation Devices and Implantable Infusion Pumps.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Neuromodulation Devices and Implantable Infusion Pumps market. It includes factors influencing customer ' purchasing decisions, preferences for Neuromodulation Devices and Implantable Infusion Pumps product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Neuromodulation Devices and Implantable Infusion Pumps market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Neuromodulation Devices and Implantable Infusion Pumps market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Neuromodulation Devices and Implantable Infusion Pumps market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Neuromodulation Devices and Implantable Infusion Pumps industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Neuromodulation Devices and Implantable Infusion Pumps market.
Market Segmentation:
Neuromodulation Devices and Implantable Infusion Pumps market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Vagal Nerve Stimulation
- Gastric Stimulation
- Transcranial Magnetic Stimulation
- Transcutaneous Electrical Stimulation
- Other
- Parkinson's Disease
- Epilepsy
- Pain
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Medtronic
- Boston Scientific Corporation
- St. Jude Medical
- Synapse Biomedical
- Nevro Corporation
- Neuropace
- Cyberonics
- Autonomic Technologies
- Avery Biomedical
- Greatbatch Medical
What is the 10-year outlook for the global Neuromodulation Devices and Implantable Infusion Pumps market?
What factors are driving Neuromodulation Devices and Implantable Infusion Pumps market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neuromodulation Devices and Implantable Infusion Pumps market opportunities vary by end market size?
How does Neuromodulation Devices and Implantable Infusion Pumps break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Neuromodulation Devices and Implantable Infusion Pumps by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Neuromodulation Devices and Implantable Infusion Pumps by Country/Region, 2019, 2023 & 2030
2.2 Neuromodulation Devices and Implantable Infusion Pumps Segment by Type
2.2.1 Spinal Cord Stimulation
2.2.2 Deep Brain Stimulation
2.2.3 Sacral Nerve Stimulation
2.2.4 Vagal Nerve Stimulation
2.2.5 Gastric Stimulation
2.2.6 Transcranial Magnetic Stimulation
2.2.7 Transcutaneous Electrical Stimulation
2.2.8 Other
2.3 Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
2.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2019-2024)
2.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Type (2019-2024)
2.3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Type (2019-2024)
2.4 Neuromodulation Devices and Implantable Infusion Pumps Segment by Application
2.4.1 Parkinson's Disease
2.4.2 Epilepsy
2.4.3 Pain
2.4.4 Other
2.5 Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
2.5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Market Share by Application (2019-2024)
2.5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Application (2019-2024)
2.5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Application (2019-2024)
3 GLOBAL NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS BY COMPANY
3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Breakdown Data by Company
3.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales by Company (2019-2024)
3.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2019-2024)
3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue by Company (2019-2024)
3.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2019-2024)
3.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2019-2024)
3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Company
3.4 Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Product Location Distribution
3.4.2 Players Neuromodulation Devices and Implantable Infusion Pumps Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS BY GEOGRAPHIC REGION
4.1 World Historic Neuromodulation Devices and Implantable Infusion Pumps Market Size by Geographic Region (2019-2024)
4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country/Region (2019-2024)
4.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales by Country/Region (2019-2024)
4.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue by Country/Region (2019-2024)
4.3 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
4.4 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
4.5 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
4.6 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
5 AMERICAS
5.1 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
5.1.1 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2024)
5.1.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2024)
5.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
5.3 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Region
6.1.1 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2019-2024)
6.1.2 APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2019-2024)
6.2 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
6.3 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neuromodulation Devices and Implantable Infusion Pumps by Country
7.1.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2024)
7.1.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2024)
7.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
7.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps by Country
8.1.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2024)
8.1.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2024)
8.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
8.3 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neuromodulation Devices and Implantable Infusion Pumps
10.3 Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps
10.4 Industry Chain Structure of Neuromodulation Devices and Implantable Infusion Pumps
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors
11.3 Neuromodulation Devices and Implantable Infusion Pumps Customer
12 WORLD FORECAST REVIEW FOR NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS BY GEOGRAPHIC REGION
12.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Region
12.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Region (2025-2030)
12.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Type
12.7 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific Corporation
13.2.1 Boston Scientific Corporation Company Information
13.2.2 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Boston Scientific Corporation Main Business Overview
13.2.5 Boston Scientific Corporation Latest Developments
13.3 St. Jude Medical
13.3.1 St. Jude Medical Company Information
13.3.2 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 St. Jude Medical Main Business Overview
13.3.5 St. Jude Medical Latest Developments
13.4 Synapse Biomedical
13.4.1 Synapse Biomedical Company Information
13.4.2 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Synapse Biomedical Main Business Overview
13.4.5 Synapse Biomedical Latest Developments
13.5 Nevro Corporation
13.5.1 Nevro Corporation Company Information
13.5.2 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Nevro Corporation Main Business Overview
13.5.5 Nevro Corporation Latest Developments
13.6 Neuropace
13.6.1 Neuropace Company Information
13.6.2 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Neuropace Main Business Overview
13.6.5 Neuropace Latest Developments
13.7 Cyberonics
13.7.1 Cyberonics Company Information
13.7.2 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Cyberonics Main Business Overview
13.7.5 Cyberonics Latest Developments
13.8 Autonomic Technologies
13.8.1 Autonomic Technologies Company Information
13.8.2 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Autonomic Technologies Main Business Overview
13.8.5 Autonomic Technologies Latest Developments
13.9 Avery Biomedical
13.9.1 Avery Biomedical Company Information
13.9.2 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Avery Biomedical Main Business Overview
13.9.5 Avery Biomedical Latest Developments
13.10 Greatbatch Medical
13.10.1 Greatbatch Medical Company Information
13.10.2 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Greatbatch Medical Main Business Overview
13.10.5 Greatbatch Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Neuromodulation Devices and Implantable Infusion Pumps by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Neuromodulation Devices and Implantable Infusion Pumps by Country/Region, 2019, 2023 & 2030
2.2 Neuromodulation Devices and Implantable Infusion Pumps Segment by Type
2.2.1 Spinal Cord Stimulation
2.2.2 Deep Brain Stimulation
2.2.3 Sacral Nerve Stimulation
2.2.4 Vagal Nerve Stimulation
2.2.5 Gastric Stimulation
2.2.6 Transcranial Magnetic Stimulation
2.2.7 Transcutaneous Electrical Stimulation
2.2.8 Other
2.3 Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
2.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2019-2024)
2.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Type (2019-2024)
2.3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Type (2019-2024)
2.4 Neuromodulation Devices and Implantable Infusion Pumps Segment by Application
2.4.1 Parkinson's Disease
2.4.2 Epilepsy
2.4.3 Pain
2.4.4 Other
2.5 Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
2.5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Market Share by Application (2019-2024)
2.5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Application (2019-2024)
2.5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Application (2019-2024)
3 GLOBAL NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS BY COMPANY
3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Breakdown Data by Company
3.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales by Company (2019-2024)
3.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2019-2024)
3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue by Company (2019-2024)
3.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2019-2024)
3.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2019-2024)
3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Company
3.4 Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Product Location Distribution
3.4.2 Players Neuromodulation Devices and Implantable Infusion Pumps Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS BY GEOGRAPHIC REGION
4.1 World Historic Neuromodulation Devices and Implantable Infusion Pumps Market Size by Geographic Region (2019-2024)
4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country/Region (2019-2024)
4.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales by Country/Region (2019-2024)
4.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue by Country/Region (2019-2024)
4.3 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
4.4 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
4.5 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
4.6 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
5 AMERICAS
5.1 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
5.1.1 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2024)
5.1.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2024)
5.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
5.3 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Region
6.1.1 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2019-2024)
6.1.2 APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2019-2024)
6.2 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
6.3 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neuromodulation Devices and Implantable Infusion Pumps by Country
7.1.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2024)
7.1.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2024)
7.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
7.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps by Country
8.1.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2024)
8.1.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2024)
8.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
8.3 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neuromodulation Devices and Implantable Infusion Pumps
10.3 Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps
10.4 Industry Chain Structure of Neuromodulation Devices and Implantable Infusion Pumps
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors
11.3 Neuromodulation Devices and Implantable Infusion Pumps Customer
12 WORLD FORECAST REVIEW FOR NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS BY GEOGRAPHIC REGION
12.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Region
12.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Region (2025-2030)
12.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Type
12.7 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific Corporation
13.2.1 Boston Scientific Corporation Company Information
13.2.2 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Boston Scientific Corporation Main Business Overview
13.2.5 Boston Scientific Corporation Latest Developments
13.3 St. Jude Medical
13.3.1 St. Jude Medical Company Information
13.3.2 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 St. Jude Medical Main Business Overview
13.3.5 St. Jude Medical Latest Developments
13.4 Synapse Biomedical
13.4.1 Synapse Biomedical Company Information
13.4.2 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Synapse Biomedical Main Business Overview
13.4.5 Synapse Biomedical Latest Developments
13.5 Nevro Corporation
13.5.1 Nevro Corporation Company Information
13.5.2 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Nevro Corporation Main Business Overview
13.5.5 Nevro Corporation Latest Developments
13.6 Neuropace
13.6.1 Neuropace Company Information
13.6.2 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Neuropace Main Business Overview
13.6.5 Neuropace Latest Developments
13.7 Cyberonics
13.7.1 Cyberonics Company Information
13.7.2 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Cyberonics Main Business Overview
13.7.5 Cyberonics Latest Developments
13.8 Autonomic Technologies
13.8.1 Autonomic Technologies Company Information
13.8.2 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Autonomic Technologies Main Business Overview
13.8.5 Autonomic Technologies Latest Developments
13.9 Avery Biomedical
13.9.1 Avery Biomedical Company Information
13.9.2 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Avery Biomedical Main Business Overview
13.9.5 Avery Biomedical Latest Developments
13.10 Greatbatch Medical
13.10.1 Greatbatch Medical Company Information
13.10.2 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Greatbatch Medical Main Business Overview
13.10.5 Greatbatch Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neuromodulation Devices and Implantable Infusion Pumps Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Neuromodulation Devices and Implantable Infusion Pumps Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Spinal Cord Stimulation
Table 4. Major Players of Deep Brain Stimulation
Table 5. Major Players of Sacral Nerve Stimulation
Table 6. Major Players of Vagal Nerve Stimulation
Table 7. Major Players of Gastric Stimulation
Table 8. Major Players of Transcranial Magnetic Stimulation
Table 9. Major Players of Transcutaneous Electrical Stimulation
Table 10. Major Players of Other
Table 11. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2019-2024) & (Unit)
Table 12. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2019-2024)
Table 13. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2019-2024) & ($ million)
Table 14. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2019-2024)
Table 15. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Type (2019-2024) & (USD/Unit)
Table 16. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2019-2024) & (Unit)
Table 17. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2019-2024)
Table 18. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2019-2024)
Table 19. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2019-2024)
Table 20. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Application (2019-2024) & (USD/Unit)
Table 21. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2019-2024) & (Unit)
Table 22. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2019-2024)
Table 23. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2019-2024) ($ Millions)
Table 24. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2019-2024)
Table 25. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Company (2019-2024) & (USD/Unit)
Table 26. Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Producing Area Distribution and Sales Area
Table 27. Players Neuromodulation Devices and Implantable Infusion Pumps Products Offered
Table 28. Neuromodulation Devices and Implantable Infusion Pumps Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Geographic Region (2019-2024) & (Unit)
Table 32. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Geographic Region (2019-2024)
Table 33. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Geographic Region (2019-2024) & ($ millions)
Table 34. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Geographic Region (2019-2024)
Table 35. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Country/Region (2019-2024) & (Unit)
Table 36. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country/Region (2019-2024)
Table 37. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country/Region (2019-2024) & ($ millions)
Table 38. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country/Region (2019-2024)
Table 39. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2024) & (Unit)
Table 40. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2019-2024)
Table 41. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2024) & ($ Millions)
Table 42. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2019-2024)
Table 43. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2019-2024) & (Unit)
Table 44. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2019-2024) & (Unit)
Table 45. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2019-2024) & (Unit)
Table 46. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2019-2024)
Table 47. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2019-2024) & ($ Millions)
Table 48. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2019-2024)
Table 49. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2019-2024) & (Unit)
Table 50. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2019-2024) & (Unit)
Table 51. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2024) & (Unit)
Table 52. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2019-2024)
Table 53. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2024) & ($ Millions)
Table 54. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2019-2024)
Table 55. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2019-2024) & (Unit)
Table 56. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2019-2024) & (Unit)
Table 57. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2024) & (Unit)
Table 58. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2019-2024)
Table 59. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2024) & ($ Millions)
Table 60. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2019-2024)
Table 61. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2019-2024) & (Unit)
Table 62. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2019-2024) & (Unit)
Table 63. Key Market Drivers & Growth Opportunities of Neuromodulation Devices and Implantable Infusion Pumps
Table 64. Key Market Challenges & Risks of Neuromodulation Devices and Implantable Infusion Pumps
Table 65. Key Industry Trends of Neuromodulation Devices and Implantable Infusion Pumps
Table 66. Neuromodulation Devices and Implantable Infusion Pumps Raw Material
Table 67. Key Suppliers of Raw Materials
Table 68. Neuromodulation Devices and Implantable Infusion Pumps Distributors List
Table 69. Neuromodulation Devices and Implantable Infusion Pumps Customer List
Table 70. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Region (2025-2030) & (Unit)
Table 71. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2025-2030) & (Unit)
Table 73. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Region (2025-2030) & (Unit)
Table 75. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Region (2025-2030) & ($ millions)
Table 76. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2025-2030) & (Unit)
Table 77. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Country (2025-2030) & ($ millions)
Table 78. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2025-2030) & (Unit)
Table 79. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Country (2025-2030) & ($ millions)
Table 80. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Type (2025-2030) & (Unit)
Table 81. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 82. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Application (2025-2030) & (Unit)
Table 83. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 84. Medtronic Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 85. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 86. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Medtronic Main Business
Table 88. Medtronic Latest Developments
Table 89. Boston Scientific Corporation Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 90. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 91. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Boston Scientific Corporation Main Business
Table 93. Boston Scientific Corporation Latest Developments
Table 94. St. Jude Medical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 95. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 96. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. St. Jude Medical Main Business
Table 98. St. Jude Medical Latest Developments
Table 99. Synapse Biomedical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 100. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 101. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Synapse Biomedical Main Business
Table 103. Synapse Biomedical Latest Developments
Table 104. Nevro Corporation Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 105. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 106. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Nevro Corporation Main Business
Table 108. Nevro Corporation Latest Developments
Table 109. Neuropace Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 110. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 111. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Neuropace Main Business
Table 113. Neuropace Latest Developments
Table 114. Cyberonics Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 115. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 116. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. Cyberonics Main Business
Table 118. Cyberonics Latest Developments
Table 119. Autonomic Technologies Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 120. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 121. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Autonomic Technologies Main Business
Table 123. Autonomic Technologies Latest Developments
Table 124. Avery Biomedical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 125. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 126. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. Avery Biomedical Main Business
Table 128. Avery Biomedical Latest Developments
Table 129. Greatbatch Medical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 130. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 131. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 132. Greatbatch Medical Main Business
Table 133. Greatbatch Medical Latest Developments
Table 1. Neuromodulation Devices and Implantable Infusion Pumps Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Neuromodulation Devices and Implantable Infusion Pumps Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Spinal Cord Stimulation
Table 4. Major Players of Deep Brain Stimulation
Table 5. Major Players of Sacral Nerve Stimulation
Table 6. Major Players of Vagal Nerve Stimulation
Table 7. Major Players of Gastric Stimulation
Table 8. Major Players of Transcranial Magnetic Stimulation
Table 9. Major Players of Transcutaneous Electrical Stimulation
Table 10. Major Players of Other
Table 11. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2019-2024) & (Unit)
Table 12. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2019-2024)
Table 13. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2019-2024) & ($ million)
Table 14. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2019-2024)
Table 15. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Type (2019-2024) & (USD/Unit)
Table 16. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2019-2024) & (Unit)
Table 17. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2019-2024)
Table 18. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2019-2024)
Table 19. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2019-2024)
Table 20. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Application (2019-2024) & (USD/Unit)
Table 21. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2019-2024) & (Unit)
Table 22. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2019-2024)
Table 23. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2019-2024) ($ Millions)
Table 24. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2019-2024)
Table 25. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Company (2019-2024) & (USD/Unit)
Table 26. Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Producing Area Distribution and Sales Area
Table 27. Players Neuromodulation Devices and Implantable Infusion Pumps Products Offered
Table 28. Neuromodulation Devices and Implantable Infusion Pumps Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Geographic Region (2019-2024) & (Unit)
Table 32. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Geographic Region (2019-2024)
Table 33. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Geographic Region (2019-2024) & ($ millions)
Table 34. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Geographic Region (2019-2024)
Table 35. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Country/Region (2019-2024) & (Unit)
Table 36. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country/Region (2019-2024)
Table 37. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country/Region (2019-2024) & ($ millions)
Table 38. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country/Region (2019-2024)
Table 39. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2024) & (Unit)
Table 40. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2019-2024)
Table 41. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2024) & ($ Millions)
Table 42. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2019-2024)
Table 43. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2019-2024) & (Unit)
Table 44. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2019-2024) & (Unit)
Table 45. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2019-2024) & (Unit)
Table 46. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2019-2024)
Table 47. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2019-2024) & ($ Millions)
Table 48. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2019-2024)
Table 49. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2019-2024) & (Unit)
Table 50. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2019-2024) & (Unit)
Table 51. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2024) & (Unit)
Table 52. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2019-2024)
Table 53. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2024) & ($ Millions)
Table 54. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2019-2024)
Table 55. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2019-2024) & (Unit)
Table 56. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2019-2024) & (Unit)
Table 57. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2024) & (Unit)
Table 58. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2019-2024)
Table 59. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2024) & ($ Millions)
Table 60. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2019-2024)
Table 61. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2019-2024) & (Unit)
Table 62. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2019-2024) & (Unit)
Table 63. Key Market Drivers & Growth Opportunities of Neuromodulation Devices and Implantable Infusion Pumps
Table 64. Key Market Challenges & Risks of Neuromodulation Devices and Implantable Infusion Pumps
Table 65. Key Industry Trends of Neuromodulation Devices and Implantable Infusion Pumps
Table 66. Neuromodulation Devices and Implantable Infusion Pumps Raw Material
Table 67. Key Suppliers of Raw Materials
Table 68. Neuromodulation Devices and Implantable Infusion Pumps Distributors List
Table 69. Neuromodulation Devices and Implantable Infusion Pumps Customer List
Table 70. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Region (2025-2030) & (Unit)
Table 71. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2025-2030) & (Unit)
Table 73. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Region (2025-2030) & (Unit)
Table 75. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Region (2025-2030) & ($ millions)
Table 76. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2025-2030) & (Unit)
Table 77. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Country (2025-2030) & ($ millions)
Table 78. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2025-2030) & (Unit)
Table 79. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Country (2025-2030) & ($ millions)
Table 80. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Type (2025-2030) & (Unit)
Table 81. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 82. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Application (2025-2030) & (Unit)
Table 83. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 84. Medtronic Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 85. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 86. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Medtronic Main Business
Table 88. Medtronic Latest Developments
Table 89. Boston Scientific Corporation Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 90. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 91. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Boston Scientific Corporation Main Business
Table 93. Boston Scientific Corporation Latest Developments
Table 94. St. Jude Medical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 95. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 96. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. St. Jude Medical Main Business
Table 98. St. Jude Medical Latest Developments
Table 99. Synapse Biomedical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 100. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 101. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Synapse Biomedical Main Business
Table 103. Synapse Biomedical Latest Developments
Table 104. Nevro Corporation Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 105. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 106. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Nevro Corporation Main Business
Table 108. Nevro Corporation Latest Developments
Table 109. Neuropace Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 110. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 111. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Neuropace Main Business
Table 113. Neuropace Latest Developments
Table 114. Cyberonics Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 115. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 116. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. Cyberonics Main Business
Table 118. Cyberonics Latest Developments
Table 119. Autonomic Technologies Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 120. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 121. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Autonomic Technologies Main Business
Table 123. Autonomic Technologies Latest Developments
Table 124. Avery Biomedical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 125. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 126. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. Avery Biomedical Main Business
Table 128. Avery Biomedical Latest Developments
Table 129. Greatbatch Medical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 130. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 131. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 132. Greatbatch Medical Main Business
Table 133. Greatbatch Medical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Neuromodulation Devices and Implantable Infusion Pumps
Figure 2. Neuromodulation Devices and Implantable Infusion Pumps Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate 2019-2030 (Unit)
Figure 7. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Spinal Cord Stimulation
Figure 10. Product Picture of Deep Brain Stimulation
Figure 11. Product Picture of Sacral Nerve Stimulation
Figure 12. Product Picture of Vagal Nerve Stimulation
Figure 13. Product Picture of Gastric Stimulation
Figure 14. Product Picture of Transcranial Magnetic Stimulation
Figure 15. Product Picture of Transcutaneous Electrical Stimulation
Figure 16. Product Picture of Other
Figure 17. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2023
Figure 18. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2019-2024)
Figure 19. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Parkinson's Disease
Figure 20. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Parkinson's Disease (2019-2024) & (Unit)
Figure 21. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Epilepsy
Figure 22. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Epilepsy (2019-2024) & (Unit)
Figure 23. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Pain
Figure 24. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Pain (2019-2024) & (Unit)
Figure 25. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Other
Figure 26. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Other (2019-2024) & (Unit)
Figure 27. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2023)
Figure 28. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application in 2023
Figure 29. Neuromodulation Devices and Implantable Infusion Pumps Sales Market by Company in 2023 (Unit)
Figure 30. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company in 2023
Figure 31. Neuromodulation Devices and Implantable Infusion Pumps Revenue Market by Company in 2023 ($ Million)
Figure 32. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company in 2023
Figure 33. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Geographic Region (2019-2024)
Figure 34. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Geographic Region in 2023
Figure 35. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales 2019-2024 (Unit)
Figure 36. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue 2019-2024 ($ Millions)
Figure 37. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales 2019-2024 (Unit)
Figure 38. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue 2019-2024 ($ Millions)
Figure 39. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales 2019-2024 (Unit)
Figure 40. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue 2019-2024 ($ Millions)
Figure 41. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales 2019-2024 (Unit)
Figure 42. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue 2019-2024 ($ Millions)
Figure 43. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country in 2023
Figure 44. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country in 2023
Figure 45. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2019-2024)
Figure 46. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2019-2024)
Figure 47. United States Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 48. Canada Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 49. Mexico Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 50. Brazil Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 51. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region in 2023
Figure 52. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Regions in 2023
Figure 53. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2019-2024)
Figure 54. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2019-2024)
Figure 55. China Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 56. Japan Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 57. South Korea Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 58. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 59. India Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 60. Australia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 61. China Taiwan Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 62. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country in 2023
Figure 63. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country in 2023
Figure 64. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2019-2024)
Figure 65. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2019-2024)
Figure 66. Germany Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 67. France Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 68. UK Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 69. Italy Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 70. Russia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 71. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country in 2023
Figure 72. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country in 2023
Figure 73. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2019-2024)
Figure 74. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2019-2024)
Figure 75. Egypt Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 76. South Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 77. Israel Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 78. Turkey Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 79. GCC Country Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 80. Manufacturing Cost Structure Analysis of Neuromodulation Devices and Implantable Infusion Pumps in 2023
Figure 81. Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps
Figure 82. Industry Chain Structure of Neuromodulation Devices and Implantable Infusion Pumps
Figure 83. Channels of Distribution
Figure 84. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Forecast by Region (2025-2030)
Figure 85. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share Forecast by Region (2025-2030)
Figure 86. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Type (2025-2030)
Figure 87. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share Forecast by Type (2025-2030)
Figure 88. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Application (2025-2030)
Figure 89. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Neuromodulation Devices and Implantable Infusion Pumps
Figure 2. Neuromodulation Devices and Implantable Infusion Pumps Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate 2019-2030 (Unit)
Figure 7. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Spinal Cord Stimulation
Figure 10. Product Picture of Deep Brain Stimulation
Figure 11. Product Picture of Sacral Nerve Stimulation
Figure 12. Product Picture of Vagal Nerve Stimulation
Figure 13. Product Picture of Gastric Stimulation
Figure 14. Product Picture of Transcranial Magnetic Stimulation
Figure 15. Product Picture of Transcutaneous Electrical Stimulation
Figure 16. Product Picture of Other
Figure 17. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2023
Figure 18. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2019-2024)
Figure 19. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Parkinson's Disease
Figure 20. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Parkinson's Disease (2019-2024) & (Unit)
Figure 21. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Epilepsy
Figure 22. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Epilepsy (2019-2024) & (Unit)
Figure 23. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Pain
Figure 24. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Pain (2019-2024) & (Unit)
Figure 25. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Other
Figure 26. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Other (2019-2024) & (Unit)
Figure 27. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2023)
Figure 28. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application in 2023
Figure 29. Neuromodulation Devices and Implantable Infusion Pumps Sales Market by Company in 2023 (Unit)
Figure 30. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company in 2023
Figure 31. Neuromodulation Devices and Implantable Infusion Pumps Revenue Market by Company in 2023 ($ Million)
Figure 32. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company in 2023
Figure 33. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Geographic Region (2019-2024)
Figure 34. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Geographic Region in 2023
Figure 35. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales 2019-2024 (Unit)
Figure 36. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue 2019-2024 ($ Millions)
Figure 37. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales 2019-2024 (Unit)
Figure 38. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue 2019-2024 ($ Millions)
Figure 39. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales 2019-2024 (Unit)
Figure 40. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue 2019-2024 ($ Millions)
Figure 41. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales 2019-2024 (Unit)
Figure 42. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue 2019-2024 ($ Millions)
Figure 43. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country in 2023
Figure 44. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country in 2023
Figure 45. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2019-2024)
Figure 46. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2019-2024)
Figure 47. United States Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 48. Canada Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 49. Mexico Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 50. Brazil Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 51. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region in 2023
Figure 52. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Regions in 2023
Figure 53. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2019-2024)
Figure 54. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2019-2024)
Figure 55. China Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 56. Japan Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 57. South Korea Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 58. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 59. India Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 60. Australia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 61. China Taiwan Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 62. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country in 2023
Figure 63. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country in 2023
Figure 64. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2019-2024)
Figure 65. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2019-2024)
Figure 66. Germany Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 67. France Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 68. UK Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 69. Italy Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 70. Russia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 71. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country in 2023
Figure 72. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country in 2023
Figure 73. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2019-2024)
Figure 74. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2019-2024)
Figure 75. Egypt Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 76. South Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 77. Israel Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 78. Turkey Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 79. GCC Country Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2019-2024 ($ Millions)
Figure 80. Manufacturing Cost Structure Analysis of Neuromodulation Devices and Implantable Infusion Pumps in 2023
Figure 81. Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps
Figure 82. Industry Chain Structure of Neuromodulation Devices and Implantable Infusion Pumps
Figure 83. Channels of Distribution
Figure 84. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Forecast by Region (2025-2030)
Figure 85. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share Forecast by Region (2025-2030)
Figure 86. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Type (2025-2030)
Figure 87. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share Forecast by Type (2025-2030)
Figure 88. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Application (2025-2030)
Figure 89. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share Forecast by Application (2025-2030)
